Cargando…
Genetic modifiers of cancer risk in Lynch syndrome: a review
The report by Aldred Scott Warthin in 1913 of a cancer family history and expanded on by Henry T. Lynch demonstrated one of the most enduring traits observed in patients with Lynch syndrome. The recognition of a variety of malignancies occurring at differing ages within a single family suggested the...
Autores principales: | Talseth-Palmer, Bente A., Wijnen, Juul T., Grice, Desma M., Scott, Rodney J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717148/ https://www.ncbi.nlm.nih.gov/pubmed/23471748 http://dx.doi.org/10.1007/s10689-013-9614-2 |
Ejemplares similares
-
A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants
por: Wiik, Mariann Unhjem, et al.
Publicado: (2021) -
Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients
por: Talseth-Palmer, Bente A, et al.
Publicado: (2013) -
Expanding the genetic basis of copy number variation in familial breast cancer
por: Masson, Amy L, et al.
Publicado: (2014) -
Lynch syndrome mutation spectrum in New South Wales, Australia, including 55 novel mutations
por: Sjursen, Wenche, et al.
Publicado: (2016) -
MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer
por: Talseth-Palmer, Bente A, et al.
Publicado: (2010)